Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Study Establishes Immune Cell Trafficking as Viable Alzheimer's Target

Study Establishes Immune Cell Trafficking as Viable Alzheimer's Target

Engineered 3D miBrains Model Human Neurovascular Units and Pathology

Engineered 3D miBrains Model Human Neurovascular Units and Pathology

3D Stem-Cell miBrains Model Complex Neurovascular Pathology in Human Tissue

3D Stem-Cell miBrains Model Complex Neurovascular Pathology in Human Tissue

Researchers Identify Peptide That Counters Key Processes of Neurodegenerative Disorders

Researchers Identify Peptide That Counters Key Processes of Neurodegenerative Disorders

Study Maps Precise Anatomical Circuits Within the Brainstem Locus Coeruleus

Study Maps Precise Anatomical Circuits Within the Brainstem Locus Coeruleus

Noninvasive Imaging Framework Enhances Predictions of Higher-Order Human Brain Function

Noninvasive Imaging Framework Enhances Predictions of Higher-Order Human Brain Function

Uncovering B Cell Signaling Pathways to Enhance Targeted T Cell Immunotherapies

Uncovering B Cell Signaling Pathways to Enhance Targeted T Cell Immunotherapies

Scientists Build a Genetic Score for Alzheimer’s Disease that Works Across Ancestries

Scientists Build a Genetic Score for Alzheimer’s Disease that Works Across Ancestries

New Platform Links Dysfunctional Biomolecular Condensates to Microcephaly and Neurodevelopment

New Platform Links Dysfunctional Biomolecular Condensates to Microcephaly and Neurodevelopment

Researchers Struggle Tracking Human Dementia Progress Using Traditional Laboratory Mice

Researchers Struggle Tracking Human Dementia Progress Using Traditional Laboratory Mice

Primate-Specific DNA Change Reveals a New Link to Dementia-Related Neurodegeneration

Primate-Specific DNA Change Reveals a New Link to Dementia-Related Neurodegeneration

Genetic Toolkit Helps Researchers Map Single Neurons in Fruit Flies

Genetic Toolkit Helps Researchers Map Single Neurons in Fruit Flies

Mapping Diverse Brain Cell Populations Unlocks Deep Hidden Molecular Secrets

Mapping Diverse Brain Cell Populations Unlocks Deep Hidden Molecular Secrets

Locally Activated Skull T Cells Halt Glioblastoma Growth in Mice

Locally Activated Skull T Cells Halt Glioblastoma Growth in Mice

Breakthrough Discovery Pinpoints How Brain Immune Cells Respond to Toxic Cellular Waste

Breakthrough Discovery Pinpoints How Brain Immune Cells Respond to Toxic Cellular Waste

New Study Links TIMP2 Loss to Microglial Immune Dysfunction

New Study Links TIMP2 Loss to Microglial Immune Dysfunction

New Roadmap Fixes Cellular Waste Accumulation to Halt Brain Degeneration

New Roadmap Fixes Cellular Waste Accumulation to Halt Brain Degeneration

Research Reevaluates Crucial Microtubule Stabilizing Protein in Dementia Progression

Research Reevaluates Crucial Microtubule Stabilizing Protein in Dementia Progression

Emerging m6A RNA Biology Explains Brain Vulnerability to Environmental Hazards

Emerging m6A RNA Biology Explains Brain Vulnerability to Environmental Hazards

Scientists Discover Altered 3D Genome Structure in Alzheimer’s Brains

Scientists Discover Altered 3D Genome Structure in Alzheimer’s Brains

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.